2013 年 59 巻 10 号 p. 658-662
We performed extraction of a third molar in a carrier of hemophilia A inhibitor who received bypass hemostatic treatment with a recombinant activated clotting factor VII( rFVIIa) preparation. The favorable results obtained are reported, along with findings from other relevant reports. A 25-year-old man known to possess hemophilia A inhibitor visited our department because of pain in the left third molar. We consulted the Division of Hematology of our hospital in preparation for tooth extraction. For hemostatic management, an rFVIIa preparation was transfused before and after the extraction procedure. The postoperative course was generally favorable.